NCT02116530
Clinical Trial Information
Trial Number: NCT02116530 (ClinicalTrials.gov)
Disease Type:
- Miscellaneous Neoplasm - Carcinoma, Miscellaneous
- Miscellaneous Neoplasm - Other
Trial Title:
Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Randomized, Double-Blind, Placebo-Controlled Trial
Study ID:
A221301
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02116530-D2 | Dataset NCT02116530-D2-Dataset.csv (aedat) is one of 2 datasets associated with PubMed ID 27410922. This dataset contains information that will allow you to reproduce the adverse events analyses. Due to cleaning efforts subsequent to the publication, the data contains some minor discrepancies from those reported in the manuscript. |
| NCT02116530-D1 | Dataset NCT02116530-D1-Dataset.csv (master) is one of 2 datasets associated with PubMed ID 27410922. This dataset contains information that will allow you to reproduce the baseline characteristics table and primary analysis. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®